GUARD-PH: Guided Use of AI-ECG for Risk Detection of PH in Surgery (GUARD-PH Trial)

This study is a prospective, open-label, randomized controlled trial designed to evaluate a new artificial intelligence (AI) tool for heart monitoring. Researchers will use an AI-enabled electrocardiography (ECG) system to screen patients before they undergo surgery. The main goal is to determine if this AI system can accurately detect pulmonary hypertension and related heart diseases in the preoperative setting. The study is being conducted at Taipei Veterans General Hospital.

NCT Number	NCT07344207
Lead Sponsor	Taipei Veterans General Hospital, Taiwan
Conditions	Pulmonary Hypertension (Diagnosis), Pre-operative Assessment, Postoperative Complications (Cardiopulmonary), Treatment Outcomes
Enrollment	1,380 participants
Start Date	2026-01-05
Primary Completion	2026-01-05 (estimated)
Study Completion	2027-01-05 (estimated)
Updated on ClinicalTrials.gov	2026-01-15